Biocon unit gets approval from Japan health authority for psoriasis treatment drug

Share it

Ustekinumab, which is a monoclonal antibody, is approved for the treatment of Psoriasis Vulgaris and Psoriatic Arthritis (PsA).

Leave a Comment

Your email address will not be published. Required fields are marked *